Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Tuberculosis | Research article

Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study

Authors: Liwen Zhang, Wei Xing, Jiani Zhou, Rui Zhang, Yong Cheng, Jin Li, Geng Wang, Shili Liu, Ying Li

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

China ranks second in the world in terms of numbers of tuberculosis (TB) cases and is one of the top three countries with the largest number of multidrug-resistant and rifampicin-resistant TB (MDR/RR-TB). It also has high mortality and low cure rates of human immunodeficiency virus (HIV)-positive TB patients. This study aimed to analyse, under the integrated TB control model, the characteristics of TB patients seeking healthcare in the largest designated TB hospital in Chongqing.

Methods

This was a retrospective study of TB registers in a health facility. Record data of 1827 TB patients who had attended the Chongqing Public Health Medical Center (CPHMC) from 1 January to 31 December 2018 were included. The Statistical Package for Social Science (SPSS 18.0; IBM Corporation, Armonk, NY, USA) was used to analyse the data. Counting data were compared using the chi-square test or Fisher’ s exact test. Among the results of the univariate analysis, the variables with statistical significance were included in the binomial stepwise logistic regression, with odds ratio and 95% confidence interval calculated. A two-tailed probability level of P < 0.05 was considered statistically significant.

Results

The majority of registered patients were men (1197), of Han ethnicity (1670), aged 21–60 years (1331), farmer/unemployed (1075), and living in county/district (1207). Approximately 24.9% of patients (455/1827) contracted DR-TB, 6% (110/1827) were co-infected with HIV, and 41.0% (749/1827) had drug-related hepatotoxicity. Among those patients, DR-TB was more likely to develop among farmers who received retreatment and had drug-related hepatotoxicity (P < 0.05). Women who received retreatment and lived in county/district were less likely to be HIV positive (P < 0.05). Compared with farmers, patients who were unemployed were more likely to be HIV positive, and those aged 21–60 years had a higher risk of being tested as HIV positive (P < 0.05).

Conclusion

Farmers who received retreatment and had drug-related hepatotoxicity are more susceptible to DR-TB; young unemployed men have a higher risk of contracting HIV-positive TB. The demographic and clinical characteristics of TB patients should be taken into consideration in DR-TB and HIV-positive TB screening in the future.
Appendix
Available only for authorised users
Literature
2.
go back to reference Shah M, Reed C. Complications of tuberculosis. Curr Opin Infect Dis. 2014;27:403–10.PubMed Shah M, Reed C. Complications of tuberculosis. Curr Opin Infect Dis. 2014;27:403–10.PubMed
5.
go back to reference Barnes PF, Bloch AB, Davidson PT, Snider DE. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991;324:1644–50.PubMed Barnes PF, Bloch AB, Davidson PT, Snider DE. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991;324:1644–50.PubMed
6.
go back to reference Hopewell PC. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis. 1992;15:540–7.PubMed Hopewell PC. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis. 1992;15:540–7.PubMed
7.
go back to reference Lucas SB, De Cock KM, Hounnou A, Peacock C, Diomande M, Honde M, et al. Contribution of tuberculosis to slim disease in Africa. BMJ. 1994;308:1531–3.PubMedPubMedCentral Lucas SB, De Cock KM, Hounnou A, Peacock C, Diomande M, Honde M, et al. Contribution of tuberculosis to slim disease in Africa. BMJ. 1994;308:1531–3.PubMedPubMedCentral
8.
go back to reference The Fifth National Tuberculosis Epidemiological Sampling Survey Technical Steering Group. The fifth National Tuberculosis Epidemiology Sampling Survey report. Chin J Ant tuberculosis. 2012;34:485–508. The Fifth National Tuberculosis Epidemiological Sampling Survey Technical Steering Group. The fifth National Tuberculosis Epidemiology Sampling Survey report. Chin J Ant tuberculosis. 2012;34:485–508.
9.
go back to reference Zhou ZW, Tao LH, Hu DY, Li Q, Ma JJ, Yi J. Analysis the epidemiological and trends of pulmonary tuberculosis from 1998 to 2009 in Chongqing and discussion on prevention and control strategies. Mod Prev Med. 2013;40:201–7. Zhou ZW, Tao LH, Hu DY, Li Q, Ma JJ, Yi J. Analysis the epidemiological and trends of pulmonary tuberculosis from 1998 to 2009 in Chongqing and discussion on prevention and control strategies. Mod Prev Med. 2013;40:201–7.
10.
go back to reference Wang Y. Report of the fifth National Sampling Survey of TB epidemiology. Beijing: Military Medical Science Press; 2011. p. 1–7p. Wang Y. Report of the fifth National Sampling Survey of TB epidemiology. Beijing: Military Medical Science Press; 2011. p. 1–7p.
11.
go back to reference Wu B, Yu Y, Xie W, Liu Y, Zhang Y, Hu D, et al. Epidemiology of tuberculosis in Chongqing, China: a secular trend from 1992 to 2015. Sci Rep. 2017;7:7832.PubMedPubMedCentral Wu B, Yu Y, Xie W, Liu Y, Zhang Y, Hu D, et al. Epidemiology of tuberculosis in Chongqing, China: a secular trend from 1992 to 2015. Sci Rep. 2017;7:7832.PubMedPubMedCentral
12.
go back to reference Chinese Center for Disease Control and Prevention. China Tuberculosis Surveillance Report. 2010. Chinese Center for Disease Control and Prevention. China Tuberculosis Surveillance Report. 2010.
13.
go back to reference Liu Y, Liu J, Jing KH, Chen I, Shen J. Analysis on monitoring results of resistance of anti-tuberculosis drug in Chongqing. Mod Prev Med. 2012;39:692–4. Liu Y, Liu J, Jing KH, Chen I, Shen J. Analysis on monitoring results of resistance of anti-tuberculosis drug in Chongqing. Mod Prev Med. 2012;39:692–4.
14.
go back to reference Duarte R, Lönnroth K, Carvalho C, Lima F, Carvalho AC, Mu Oz-Torrico M, et al. Tuberculosis, social determinants and co-morbidities (including HIV). Pulmonology. 2017;24:115–9.PubMed Duarte R, Lönnroth K, Carvalho C, Lima F, Carvalho AC, Mu Oz-Torrico M, et al. Tuberculosis, social determinants and co-morbidities (including HIV). Pulmonology. 2017;24:115–9.PubMed
15.
go back to reference Chen WY, Wei X. Li T, Chen H. analysis of global and Chinese tuberculosis epidemics in 2015. J Tuberc Lung Health. 2016;1:32–3616. Chen WY, Wei X. Li T, Chen H. analysis of global and Chinese tuberculosis epidemics in 2015. J Tuberc Lung Health. 2016;1:32–3616.
16.
go back to reference Zou GY, Wei XL, Walley JD, Yin J, Sun Q. Factors influencing integration of TB services in general hospitals in two regions of China: a qualitative study. BMC Health Serv Res. 2012;12:21.PubMedPubMedCentral Zou GY, Wei XL, Walley JD, Yin J, Sun Q. Factors influencing integration of TB services in general hospitals in two regions of China: a qualitative study. BMC Health Serv Res. 2012;12:21.PubMedPubMedCentral
17.
go back to reference National Health and Family Planning Commission of the people's Republic of China. Diagnosis for pulmonary tuberculosis. 2017. National Health and Family Planning Commission of the people's Republic of China. Diagnosis for pulmonary tuberculosis. 2017.
18.
go back to reference Department of Disease Control and Department of Medical Administration of Ministry of Health of PRC, Chinese Center for Disease Control and Prevention. Guidelines for implementing the national tuberculosis control program in China. Beijing: Peking Union Medical College Press; 2008. Department of Disease Control and Department of Medical Administration of Ministry of Health of PRC, Chinese Center for Disease Control and Prevention. Guidelines for implementing the national tuberculosis control program in China. Beijing: Peking Union Medical College Press; 2008.
20.
go back to reference Huang F, Cheng S, Du X, Chen W, Scano F, Falzon D, et al. Electronic recording and reporting system for tuberculosis in China: experience and opportunities. J Am Med Inform Assoc. 2014;21:938–41.PubMed Huang F, Cheng S, Du X, Chen W, Scano F, Falzon D, et al. Electronic recording and reporting system for tuberculosis in China: experience and opportunities. J Am Med Inform Assoc. 2014;21:938–41.PubMed
21.
go back to reference World Health Organization (WHO). Extensively DR tuberculosis (XDR.TB): recommendations for prevention and control. Wkly Epidemiol Rec. 2006;81:430–2. World Health Organization (WHO). Extensively DR tuberculosis (XDR.TB): recommendations for prevention and control. Wkly Epidemiol Rec. 2006;81:430–2.
22.
go back to reference World Health Organization (WHO). Treatment guidelines for multidrug and rifampicin-resistant tuberculosis, 2018. World Health Organization (WHO). Treatment guidelines for multidrug and rifampicin-resistant tuberculosis, 2018.
23.
go back to reference Wang Y, Zhang FM, Luo KW, Meng J. Regional and occupational distribution of 335 MDR-TB cases in Guizhou Province. J Guiyang Med College. 2012;37:302–3. Wang Y, Zhang FM, Luo KW, Meng J. Regional and occupational distribution of 335 MDR-TB cases in Guizhou Province. J Guiyang Med College. 2012;37:302–3.
24.
go back to reference Pu J, Chen W, Jiang WX, Xing W, Liang SX, Li Y, et al. Is tuberculosis patients management improved in the integrated TB control model in West China? A survey in Guizhou Province, China. Infect Dis Poverty. 2018;81:55. Pu J, Chen W, Jiang WX, Xing W, Liang SX, Li Y, et al. Is tuberculosis patients management improved in the integrated TB control model in West China? A survey in Guizhou Province, China. Infect Dis Poverty. 2018;81:55.
25.
go back to reference Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011;101:654–62.PubMedPubMedCentral Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011;101:654–62.PubMedPubMedCentral
27.
go back to reference Wang H, Pan JP, Zhang TH, Ai XQ, Han YL, Wang WQ, et al. Survey on the knowledge, attitude and behaviors of TB among college students. Chin J Public Health. 2006;22:661–2. Wang H, Pan JP, Zhang TH, Ai XQ, Han YL, Wang WQ, et al. Survey on the knowledge, attitude and behaviors of TB among college students. Chin J Public Health. 2006;22:661–2.
28.
go back to reference Du X, Chen W, Huang F. Analysis on TB of national report of students TB during 2004–2008. Chin Health Educ. 2009;25:803–5. Du X, Chen W, Huang F. Analysis on TB of national report of students TB during 2004–2008. Chin Health Educ. 2009;25:803–5.
29.
go back to reference Zhou S, Chen M. Epidemiology survey on outbreaks of TB in the universities in Chongqing. Health Med Res Pract Higher Inst. 2005;2:7–10. Zhou S, Chen M. Epidemiology survey on outbreaks of TB in the universities in Chongqing. Health Med Res Pract Higher Inst. 2005;2:7–10.
30.
go back to reference Pang Y, Wu CG, Liu Y, Zhang T, Duan WX, Yu Y, et al. Analysis of the disposal of tuberculosis clusters in schools in Chongqing in 2017. Chin J Tropical Med. 2019;1:97–9. Pang Y, Wu CG, Liu Y, Zhang T, Duan WX, Yu Y, et al. Analysis of the disposal of tuberculosis clusters in schools in Chongqing in 2017. Chin J Tropical Med. 2019;1:97–9.
31.
go back to reference Pang Y, Liu Y, Wang QY. An overview of the prevalence of tuberculosis epidemics in schools in Chongqing in 2016. Pract Prev Med. 2018;1:10–3. Pang Y, Liu Y, Wang QY. An overview of the prevalence of tuberculosis epidemics in schools in Chongqing in 2016. Pract Prev Med. 2018;1:10–3.
32.
go back to reference Zhao Y, Ehiri J, Li D, Luo X, Ying L. A survey of TB knowledge among medical students in Southwest China: is the information reaching the target? BMJ Open. 2013;3:e003454.PubMedPubMedCentral Zhao Y, Ehiri J, Li D, Luo X, Ying L. A survey of TB knowledge among medical students in Southwest China: is the information reaching the target? BMJ Open. 2013;3:e003454.PubMedPubMedCentral
33.
go back to reference Wang QY, Hu DY, Liu Y, Shen J. Chongqing City tuberculosis drug resistance analysis. Chongqing Med. 2014;22:2913–5. Wang QY, Hu DY, Liu Y, Shen J. Chongqing City tuberculosis drug resistance analysis. Chongqing Med. 2014;22:2913–5.
34.
go back to reference Zhang W, Hu DY, Liu Y, Yu Y, Su Q, Zhang T. Prevalence of multidrug-resistance in 638 tuberculosis patients in Chongqing. Chin J Tropical Med. 2017;17:231–5. Zhang W, Hu DY, Liu Y, Yu Y, Su Q, Zhang T. Prevalence of multidrug-resistance in 638 tuberculosis patients in Chongqing. Chin J Tropical Med. 2017;17:231–5.
35.
go back to reference Yu HY, Zhang W, Lu RR, Wu GH, Su K, Zhang Y, et al. The epidemiological characteristics and long-term trend of HIV infection and AIDS in Chongqing from 1995 to 2015. J Third Mil Med Univ. 2017;20:2051–8. Yu HY, Zhang W, Lu RR, Wu GH, Su K, Zhang Y, et al. The epidemiological characteristics and long-term trend of HIV infection and AIDS in Chongqing from 1995 to 2015. J Third Mil Med Univ. 2017;20:2051–8.
37.
go back to reference Tsiouris SJ, Gandhi NR, El-Sadr WM, Friedland G. Tuberculosis and HIV-needed: a new paradigm for the control and management of linked epidemics. J Int AIDS Soc. 2007;9:62.PubMedPubMedCentral Tsiouris SJ, Gandhi NR, El-Sadr WM, Friedland G. Tuberculosis and HIV-needed: a new paradigm for the control and management of linked epidemics. J Int AIDS Soc. 2007;9:62.PubMedPubMedCentral
38.
go back to reference Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008;300:423–30.PubMed Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008;300:423–30.PubMed
39.
go back to reference Story A, Murad S, Roberts W, Verheyen M, Hayward AC. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax. 2007;62:667–71.PubMedPubMedCentral Story A, Murad S, Roberts W, Verheyen M, Hayward AC. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax. 2007;62:667–71.PubMedPubMedCentral
40.
go back to reference Dubrovina I, Miskinis K, Lyepshina S, Yann Y, Zignol M. DR tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics? Int J Tuberc Lung Dis. 2008;12:756–62.PubMed Dubrovina I, Miskinis K, Lyepshina S, Yann Y, Zignol M. DR tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics? Int J Tuberc Lung Dis. 2008;12:756–62.PubMed
41.
go back to reference Wright A, Zignol M, Van Deun A, Falzon D, Gerdes S, Feldman K, et al. Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the global project on anti-tuberculosis drug resistance surveillance. Lancet. 2009;373:1861–73.PubMed Wright A, Zignol M, Van Deun A, Falzon D, Gerdes S, Feldman K, et al. Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the global project on anti-tuberculosis drug resistance surveillance. Lancet. 2009;373:1861–73.PubMed
42.
go back to reference Gandhi NR, Nunn P, Dheda K, Schaaf HS, Bayona J. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–43.PubMed Gandhi NR, Nunn P, Dheda K, Schaaf HS, Bayona J. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–43.PubMed
43.
go back to reference Shao Y, Yang D, Xu W, Lu W, Wang J. Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead. BMC Public Health. 2011;11:110.PubMedPubMedCentral Shao Y, Yang D, Xu W, Lu W, Wang J. Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead. BMC Public Health. 2011;11:110.PubMedPubMedCentral
44.
go back to reference Pam OI, Noel O, Susan O, Florence M, Joshua N, Pere-Joan C. Prevalence of drug resistance Mycobacterium tuberculosis among patients seen in coast provincial general hospital, mombasa, kenya. PLoS One. 2016;11:e0163994. Pam OI, Noel O, Susan O, Florence M, Joshua N, Pere-Joan C. Prevalence of drug resistance Mycobacterium tuberculosis among patients seen in coast provincial general hospital, mombasa, kenya. PLoS One. 2016;11:e0163994.
45.
go back to reference Zhou Y. Analysis of risk factors of drug-induced liver injury induced by antituberculous therapy. Chin J Clin Ration Drug Use. 2018;11:54–5. Zhou Y. Analysis of risk factors of drug-induced liver injury induced by antituberculous therapy. Chin J Clin Ration Drug Use. 2018;11:54–5.
46.
go back to reference Hutchison C, Khan MS, Yoong J, Lin X, Coker RJ. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China. BMC Public Health. 2017;17:221.PubMedPubMedCentral Hutchison C, Khan MS, Yoong J, Lin X, Coker RJ. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China. BMC Public Health. 2017;17:221.PubMedPubMedCentral
47.
go back to reference Bastard M, Sanchez-Padilla E, du Cros P, Khamraev AK, Parpieva N, Tillyashaykov M, et al. Outcomes of HIV-infected versus HIV-non infected patients treated for drug-resistance. tuberculosis: Multicenter cohort study. PLoS One. 2018;13:e0193491.PubMedPubMedCentral Bastard M, Sanchez-Padilla E, du Cros P, Khamraev AK, Parpieva N, Tillyashaykov M, et al. Outcomes of HIV-infected versus HIV-non infected patients treated for drug-resistance. tuberculosis: Multicenter cohort study. PLoS One. 2018;13:e0193491.PubMedPubMedCentral
48.
go back to reference Mao SY, Xu SX. Comparative analysis of drug resistance of AIDS combined with tuberculosis and simple tuberculosis. Med Front. 2016;2:38. Mao SY, Xu SX. Comparative analysis of drug resistance of AIDS combined with tuberculosis and simple tuberculosis. Med Front. 2016;2:38.
49.
go back to reference Xia H. A molecular epidemiological study on HIV/AIDS patients of Han nationality from Chongqing. China: Third Military Medical University; 2009. Xia H. A molecular epidemiological study on HIV/AIDS patients of Han nationality from Chongqing. China: Third Military Medical University; 2009.
Metadata
Title
Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study
Authors
Liwen Zhang
Wei Xing
Jiani Zhou
Rui Zhang
Yong Cheng
Jin Li
Geng Wang
Shili Liu
Ying Li
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05304-z

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.